CELF1 and myotonic dystrophy type 1: Altered response to stress and abnormal clearance of SGs caused by MBNL1/CELF1 disruption have been suggested as one of the pathomechanisms in DM1 and treatments that selectively target pathological SGs might be considered a potential therapeutic strategy [62,63].